BackBioPlus Acquisition Overview

BioPlus Acquisition Total Liabilities

Latest total liabilities for BIOS: $17M.

Get informed when a big investor buys or sells

+ Follow
Total Liabilities
$16.78M
11.55% YoYΔ $1.74M vs prior year quarter

Peer trimmed avg / median

Loading

BioPlus Acquisition Total Liabilities History

Loading

BioPlus Acquisition vs. peers: Total Liabilities Comparison

Loading

BioPlus Acquisition Total Liabilities Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

BioPlus Acquisition (BIOS) FAQ

As of the most recent data (June 2023), BIOS shows a total liabilities of $17M. That compares with $15M in the prior-year period — up 11.6% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, BIOS's total liabilities is now $17M (was $15M) — a 11.6% year-over-year increase. Pairing that YoY change with peer averages gives a clearer picture of whether BioPlus Acquisition is outperforming or lagging.

Tracking BIOS's total liabilities over time shows whether BioPlus Acquisition is scaling, shrinking, or reshaping that part of the business. The current reading is $17M That compares with $15M in the prior-year period — up 11.6% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this total liabilities page, Stockcircle has BioPlus Acquisition's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect total liabilities (currently $17M) with ownership activity and broader fundamentals.